Endotoxin in the gut and chylomicrons: Translocation or transportation?

Journal of Lipid Research

Volumn 50, Issue 1, 2009, Pages 1-2

  Grunfeld, Carl ^a   Feingold, Kenneth R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; ENDOTOXIN; LIPOPROTEIN; LIPID;

ENDOTOXEMIA; FAT INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; MESENTERY LYMPH NODE; METABOLIC DISORDER; NONHUMAN; NOTE; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; IMMUNE SYSTEM; INTESTINE; INTESTINE ABSORPTION; METABOLISM; MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CHYLOMICRONS; ENDOTOXINS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INTESTINAL ABSORPTION; INTESTINES; LIPIDS; LIPOPROTEINS; MICE; MODELS, BIOLOGICAL;

EID: 63449088943     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E800018-JLR200     Document Type: Note

References (23)

1. Backhed, F., J. K. Manchester, C. F. Semenkovich, and J. I. Gordon. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA. 104: 979-984.
2. Backhed, F., H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich, and J. I. Gordon. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 101: 15718-15723.
3. Membrez, M., F. Blancher, M. Jaquet, R. Bibiloni, P. D. Cani, R. G. Burcelin, I. Corthesy, K. Mace, and C. J. Chou. 2008. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 22: 2416-2426.
4. Cani, P. D., R. Bibiloni, C. Knauf, A. Waget, A. M. Neyrinck, N. M. Delzenne, and R. Burcelin. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 57: 1470-1481.
5. Ley, R. E., F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 102: 11070-11075.
6. Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444: 1027-1031.
7. Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 56: 1761-1772.
8. Amar, J., R. Burcelin, J. B. Ruidavets, P. D. Cani, J. Fauvel, M. C. Alessi, B. Chamontin, and J. Ferrieres. 2008. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 87: 1219-1223.
9. Creely, S. J., P. G. McTernan, C. M. Kusminski, M. Fisher, N. F. Da Silva, M. Khanolkar, M. Evans, A. L. Harte, and S. Kumar. 2007. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292: E740-E747.
10. Erridge, C., T. Attina, C. M. Spickett, and D. J. Webb. 2007. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 86: 1286-1292.
11. Caradonna, L., L. Amati, T. Magrone, N. M. Pellegrino, E. Jirillo, and D. Caccavo. 2000. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J. Endotoxin Res. 6: 205-214.
12. Purohit, V., J. C. Bode, C. Bode, D. A. Brenner, M. A. Choudhry, F. Hamilton, Y. J. Kang, A. Keshavarzian, R. Rao, R. B. Sartor, et al. 2008. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol. 42: 349-361.
13. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
14. Yao, Y. M., S. Bahrami, G. Leichtfried, H. Redl, and G. Schlag. 1995. Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein. Ann. Surg. 221: 398-405.
15. Luyer, M. D., J. A. Jacobs, A. C. Vreugdenhil, M. Hadfoune, C. H. Dejong, W. A. Buurman, and J. W. Greve. 2004. Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial translocation. Ann. Surg. 239: 257-264.
16. Luyer, M. D., W. A. Buurman, M. Hadfoune, J. A. Jacobs, C. H. Dejong, and J. W. Greve. 2004. High-fat enteral nutrition reduces endotoxin, tumor necrosis factor-alpha and gut permeability in bile duct-ligated rats subjected to hemorrhagic shock. J. Hepatol. 41: 377-383.
17. Luyer, M. D., W. A. Buurman, M. Hadfoune, J. A. Jacobs, S. R. Konstantinov, C. H. Dejong, and J. W. Greve. 2004. Pretreatment with high-fat enteral nutrition reduces endotoxin and tumor necrosis factor-alpha and preserves gut barrier function early after hemorrhagic shock. Shock. 21: 65-71.
18. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196.
19. Harris, H. W., C. Grunfeld, K. R. Feingold, T. E. Read, J. P. Kane, A. L. Jones, E. B. Eichbaum, G. F. Bland, and J. H. Rapp. 1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91: 1028-1034.
20. Ghoshal, S., J. Witta, J. Zhong, W. de Villiers, and E. Eckhardt. 2008. Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 50: 90-97.
21. Guadalupe, M., E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar. 2003. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77: 11708-11717.
22. Brenchley, J. M., T. W. Schacker, L. E. Ruff, D. A. Price, J. H. Taylor, G. J. Beilman, P. L. Nguyen, A. Khoruts, M. Larson, A. T. Haase, et al. 2004. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
23. Read, T. E., C. Grunfeld, Z. L. Kumwenda, M. C. Calhoun, J. P. Kane, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182: 267-272.